×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [4]
中国医学科学院 北京... [2]
江苏大学 [1]
吉林大学白求恩第一医... [1]
吉林大学白求恩第三医... [1]
近代物理研究所 [1]
更多...
内容类型
期刊论文 [10]
发表日期
2017 [10]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共10条,第1-10条
帮助
限定条件
发表日期:2017
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
A network meta-analysis on the efficacy of targeted agents in combination with chemotherapy for treatment of advanced/metastatic triple-negative breast cancer
期刊论文
ONCOTARGET, 2017, 卷号: 8, 页码: 59539-59551
作者:
Ge, Long
;
Tang, Yan
;
Zhang, Qiu-Ning
;
Tian, Jin-Hui
;
Wang, Xiao-Hu
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2018/05/31
targeted agents
chemotherapy
triple-negative breast cancer
network meta-analysis
randomized controlled trials
Efficacy and safety of traditional chemotherapies for patients with ovarian neoplasm: a network meta-analysis
期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 35
作者:
Sun, Liqun
;
Guo, Gongliang
;
Yang, Lili
;
Zhang, Haipeng
;
Li, Chenhao
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2019/12/05
ovarian neoplasm
network meta-analysis
carboplatin
pegylated liposomal doxorubicin
paclitaxel
Efficacy and safety of traditional chemotherapies for patients with ovarian neoplasm: a network meta-analysis
期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 35
作者:
Yang, Lili
;
Guo, Gongliang
;
Sun, Liqun
;
Li, Chenhao
;
Zhang, Haipeng
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
ovarian neoplasm
network meta-analysis
carboplatin
pegylated liposomal doxorubicin
paclitaxel
Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer
期刊论文
ONCOTARGETS AND THERAPY, 2017, 卷号: 10
作者:
Huang, Liang
;
Liu, Qi
;
Chen, Sheng
;
Shao, Zhiming
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
neoadjuvant chemotherapy
triple negative breast cancer
carboplatin
cisplatin
pathological complete response
Predictive factors of pathologic complete response in HER2-positive and axillary lymph node positive breast cancer after neoadjuvant paclitaxel, carboplatin plus with trastuzumab
期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 34
作者:
Ding, Jinhua
;
Yang, Yinlong
;
Jiang, Li
;
Wu, Weizhu
;
Shao, Zhiming
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/05
breast cancer
neoadjuvant chemotherapy
human epidermal growth factor receptor 2 (HER2)
Ki67
pathological complete response (pCR)
Weekly paclitaxel plus carboplatin with or without trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancer: loss of HER2 amplification and its impact on response and prognosis
期刊论文
BREAST CANCER RESEARCH AND TREATMENT, 2017, 卷号: 161, 期号: 2
作者:
Wang, Ruo-Xi
;
Chen, Sheng
;
Jin, Xi
;
Chen, Can-Ming
;
Shao, Zhi-Ming
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/05
Breast cancer
Neoadjuvant chemotherapy
HER2-positive
Pathological complete response
Trastuzumab
Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial
期刊论文
ANNALS OF ONCOLOGY, 2017, 卷号: 28, 期号: 4
作者:
Liang, J.
;
Bi, N.
;
Wu, S.
;
Chen, M.
;
Lv, C.
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/05
non-small cell lung cancer
locally advanced
chemoradiotherapy
cisplatin and etoposide
carboplatin and paclitaxel
Metastatic Microcystic Adnexal Carcinoma with DNA Sequencing Results and Response to Systemic Antineoplastic Chemotherapy
期刊论文
ANTICANCER RESEARCH, 2017, 卷号: 37, 期号: 9, 页码: 5109-5111
作者:
Chen, Min-Bin[1]
;
Laber, Damian A.[2]
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/24
Microcystic adnexal carcinoma
carboplatin
paclitaxel
next-generation sequencing
Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial
期刊论文
2017, 卷号: 28, 期号: 4, 页码: 777-783
作者:
Liang, J.
;
Bi, N.
;
Wu, S.
;
Chen, M.
;
Lv, C.
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2020/01/03
non-small cell lung cancer
locally advanced
chemoradiotherapy
cisplatin and etoposide
carboplatin and paclitaxel
Response to 'Survival advantage for etoposide/ cisplatin over paclitaxel/carboplatin concurrent chemoradiation in patients with inoperable stage III NSCLC: a subgroup analysis for ECOG 2 patients would be of great interest'
期刊论文
2017, 卷号: 28, 期号: 12, 页码: 3101-3103
作者:
Bi, N.
;
Liang, J.
;
Wang, L.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
Chemoradiotherapy
concomitant
inoperable
locally-advanced NSCLC
performance status
©版权所有 ©2017 CSpace - Powered by
CSpace